137 related articles for article (PubMed ID: 16734360)
21. In vitro activity of cefoperazone-sulbactam: Singapore experience.
Kumarasinghe G; Chow C; Chiu C; Cheong YM
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):734-7. PubMed ID: 9253876
[TBL] [Abstract][Full Text] [Related]
22. [Treatment approaches for bronchopulmonary infection in myasthenia gravis patients].
Sokolova VI; Sanadze AG; Sychev DA; Babarina MB; Zaĭkov DA
Antibiot Khimioter; 2014; 59(1-2):20-3. PubMed ID: 25051712
[TBL] [Abstract][Full Text] [Related]
23. [Antibiotic resistance of gramnegative nosocomial pathogens in Minsk ICUs].
Iliukevich GV; Smirnov VM; Levshina NN
Antibiot Khimioter; 2009; 54(11-12):25-31. PubMed ID: 20583564
[TBL] [Abstract][Full Text] [Related]
24. [In vitro activity of ampicillin and ampicillin-sulbactam on diverse bacteria].
Trucco O; Prado V; Mollinedo E; Cordoves A
Rev Med Chil; 1989 Jul; 117(7):747-54. PubMed ID: 2519428
[TBL] [Abstract][Full Text] [Related]
25. [Microorganisms isolated from urinary tract infection and their beta-lactamase production and evaluation of clinical efficacy of sulperazone].
Kawamura J; Hayashi N; Okabe S; Kawahara S; Chigusa I; Araki T; Saito K; Takeno K; Suzuki N; Suzuki I
Hinyokika Kiyo; 1988 Aug; 34(8):1503-14. PubMed ID: 3057834
[TBL] [Abstract][Full Text] [Related]
26. [In vitro antibacterial activity of sulperazone on multi-resistant strains of bacteria from burn wounds].
Xu W; Chen X
Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):390-2. PubMed ID: 8565723
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of cefoperazone-sulbactam combination against gram negative bacilli.
Poudyal N; Gyawali N; Gurung R; Bhattarai NR; Baral R; Khanal B; Shrestha S; Amatya R; Bhattacharya SK
Nepal Med Coll J; 2012 Mar; 14(1):5-8. PubMed ID: 23441486
[TBL] [Abstract][Full Text] [Related]
28. In vitro assessment of sulbactam plus cefoperazone in the treatment of bacteria isolated from cancer patients.
Bodey GP; Miller P; Ho DH
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):209S-214S. PubMed ID: 2591178
[TBL] [Abstract][Full Text] [Related]
29. Therapy with cefoperazone plus sulbactam against disseminated infection due to cefoperazone-resistant Pseudomonas aeruginosa and Escherichia coli in granulocytopenic mice.
Chandrasekar PH; Sluchak JA; Kruse JA
Antimicrob Agents Chemother; 1993 Sep; 37(9):1927-30. PubMed ID: 8239607
[TBL] [Abstract][Full Text] [Related]
30. [A randomized clinical study of sulperazone versus tienam in the treatment of LRTIS].
Li J; Zhu Y; Hu W
Zhonghua Nei Ke Za Zhi; 1996 Dec; 35(12):819-23. PubMed ID: 9592308
[TBL] [Abstract][Full Text] [Related]
31. [Modern possibilities of hepacef combi (cefoperazon/sulbactam) application for the treatment of surgical infection].
Herych ID; Vashchuk VV
Klin Khir; 2011 Feb; (2):65-9. PubMed ID: 21548334
[No Abstract] [Full Text] [Related]
32. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
Xiao QZ; Su DH; Jiang JH; Zhong NS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
[TBL] [Abstract][Full Text] [Related]
33. [Comparative estimation of the application efficacy for ceftriaxon and Hepacef combi preparations in the abdominal infection treatment].
Boĭko VV; Ivanova IuV
Klin Khir; 2012 Jan; (1):30-2. PubMed ID: 22642085
[TBL] [Abstract][Full Text] [Related]
34. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
Suzuki K; Horiba M
Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
[TBL] [Abstract][Full Text] [Related]
35. Cefoperazone/sulbactam + co-trimoxazole vs ceftazidime + co-trimoxazole in the treatment of severe melioidosis: a randomized, double-blind, controlled study.
Thamprajamchit S; Chetchotisakd P; Thinkhamrop B
J Med Assoc Thai; 1998 Apr; 81(4):265-71. PubMed ID: 9623020
[TBL] [Abstract][Full Text] [Related]
36. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
37. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
38. [Antibiotic susceptibility of isolates from blood of patients in intensive care units of emergency medical service].
Chernen'kaia TV; Borisova LA; Vorob'eva TIu; Aleksandrova IV; Kosolapov DA
Antibiot Khimioter; 2011; 56(5-6):30-6. PubMed ID: 22145228
[TBL] [Abstract][Full Text] [Related]
39. [A randomized controlled clinical trial of sulperazone as compared with cefotaxime in the treatment of bacterial infections].
Li J; Miao J; Hu W
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):680-2. PubMed ID: 8731830
[TBL] [Abstract][Full Text] [Related]
40. Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.
Liu JW; Chen YH; Lee WS; Lin JC; Huang CT; Lin HH; Liu YC; Chuang YC; Tang HJ; Chen YS; Ko WC; Lu MC; Wang FD
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
